BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth


2/1/2011 6:30:13 AM

CINCINNATI, Feb. 1, 2011 /PRNewswire/ -- AssureRx Health, Inc. today announced the appointments of two senior executives in key roles to drive company growth. Donald R. Wright, Jr. has been appointed as executive vice president & chief operating officer and John A. Bellano as senior vice president, sales & commercial programs.

Wright has been instrumental in leading the development of AssureRx's pharmacogenetic test, GeneSightRx®, and the blueprint of products the company expects to develop over the next two to three years. In his new position, Wright will play a fundamental role in leading AssureRx's future product offerings, operations, and external relationships and he will continue managing software product development, overseeing information technology and molecular genetics laboratory operations, as well as customer support, field sales support, quality assurance, and human resources. Wright brings over 20 years of software product development and operations expertise, including Attachmate where he led a 700 member software team and the creation and support of a $450 million software product line. Wright also served as chief technology officer and chief information officer in various software companies and has participated in more than 25 successful product launches.

Bellano is joining AssureRx as a key member of the executive team, leading the company's sales efforts to increase adoption of GeneSightRx, launching new products in development, and leading the company's efforts with Diamond Healthcare and other strategic partners. Bellano also brings 20 years of experience to AssureRx, most recently as senior vice president, commercial operations for GenMark, a molecular diagnostics company, and as vice president, sales for Hologic Inc., a developer and manufacturer of women's health care products and systems. Prior to Hologic, Bellano served as vice president, sales for Third Wave, a provider of DNA and RNA products for the clinical and research markets, where he played a key role in building market adoption that led to Third Wave's acquisition by Hologic. Prior to Third Wave, John held various molecular diagnostic sales positions with Roche Diagnostics, Sanofi Diagnostics Pasteur, Abbott Laboratories and Forest Laboratories.

"Our goal is to build the leading medical informatics company providing pharmacogenetic and other clinical decision support products to help physicians individualize the treatment of patients with neuropsychiatric and other disorders," said James S. Burns, president & CEO of AssureRx. "Strengthening the leadership team is an important step for AssureRx this year as we build sales momentum and launch our second product. Don and John have the leadership skills and experience to meet our customers' needs for treatment support products that can help improve patient care at substantially reduced costs."

About AssureRx Health

AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenetics and other treatment decision support products to help physicians determine the right drug and the right dose for individual patients suffering from neuropsychiatric disorders. The company was founded in 2006 to commercialize industry-leading personalized medicine technology. Cincinnati Children's Hospital Medical Center and Mayo Clinic are equity holders and technology collaborators.

About GeneSightRx®

GeneSightRx® is a laboratory developed genetic test that uses leading edge technology to measure and analyze clinically important genetic variants that affect how individuals metabolize psychiatric medicine. The test results can help a doctor understand the way a patient's unique genetic makeup may affect certain psychiatric drugs. The analysis is based on pharmacogenetics, the study of the genetic factors that influence an individual's response to drug treatments, incorporating FDA approved manufacturers' drug labels, peer-reviewed scientific publications, and proven pharmacology. Quick turnaround time, combined with a customized report of the patient's genetic makeup, clinical experience, and other factors can help a physician make personalized drug treatment choices for each individual patient. To learn more about pharmacogenetics and GeneSightRx, please click here. Be sure to watch the educational video.

Contacts:

James S. Burns

President & CEO

AssureRx Health, Inc.

Tel: (513) 234-0510

e-mail: jburns@assurerxhealth.com


Andreas Marathovouniotis or David Schull

Russo Partners

Tel: (212) 845-4235 or (212) 845-4271

e-mail: andreas.marathis@russopartnersllc.com or david.schull@russopartnersllc.com



SOURCE AssureRx Health, Inc.



Read at BioSpace.com

AssureRx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES